Disease Markers

Disease Markers / 2007 / Article
Special Issue

Biomarkers in Ovarian Disease

View this Special Issue

Open Access

Volume 23 |Article ID 474320 | https://doi.org/10.1155/2007/474320

Samuel C. Mok, Joseph Kwong, William R. Welch, Goli Samimi, Laurent Ozbun, Tomas Bonome, Michael J. Birrer, Ross S. Berkowitz, Kwong-Kwok Wong, "Etiology and Pathogenesis of Epithelial Ovarian Cancer", Disease Markers, vol. 23, Article ID 474320, 10 pages, 2007. https://doi.org/10.1155/2007/474320

Etiology and Pathogenesis of Epithelial Ovarian Cancer

Received09 Nov 2007
Accepted09 Nov 2007

Abstract

Ovarian cancer is complex disease composed of different histological grades and types. However, the underlying molecular mechanisms involved in the development of different phenotypes remain largely unknown. Epidemiological studies identified multiple exogenous and endogenous risk factors for ovarian cancer development. Among them, an inflammatory stromal microenvironment seems to play a critical role in the initiation of the disease. The interaction between such a microenvironment, genetic polymorphisms, and different epithelial components such as endosalpingiosis, endometriosis, and ovarian inclusion cyst in the ovarian cortex may induce different genetic changes identified in the epithelial component of different histological types of ovarian tumors. Genetic studies on different histological grades and types provide insight into the pathogenetic pathways for the development of different disease phenotypes. However, the link between all these genetic changes and the etiological factors remains to be established.

Copyright © 2007 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views532
Downloads624
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.